| 02/03 | Yiling Pharma Gets Regulatory Nod for Traditional Chinese Medicine | MT |
| 02/03 | Buchang Pharmaceuticals Plans to Set Up Headquarters at Shijiazhuang International Biom.. | MT |
| 02/03 | Yiling Pharma's Antibiotic Passes Consistency Test | MT |
| 02/01 | Buchang Pharmaceuticals Unit Gets Production License from Chinese Provincial Drug Regul.. | MT |
| 01/30 | Dong-E-E-Jiao Expects Up to 810 Million Yuan in 2022 Profit; Shares Rise 4% | MT |
| 01/30 | Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Year Ended December 31, 2022 | CI |
| 01/20 | Shijiazhuang Yiling’s Depression Drug Included in China’s Medical Insurance.. | MT |
| 01/08 | Yiling Pharma’s Traditional Chinese Medicine Added to Government's Recommended Dr.. | MT |
| 01/03 | Gloom and boom: Fund managers' top picks for 2023 | RE |
| 2022 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Appoints Mao Weiwen as Non.. | CI |
| 2022 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Cessation of Won.. | CI |
| 2022 | Chinese Shares End Year With Modest Gains; Two Shenzhen Debutants Post Mixed Results | MT |
| 2022 | China stocks jump on easing COVID curbs | RE |
| 2022 | China stocks rise on further eased COVID rules | RE |
| 2022 | Shijiazhuang Yiling Pharma Secures Regulatory Nod For Traditional Chinese Medicine Tria.. | MT |
| 2022 | Yiling Pharma Denies Claims That COVID-19 Drug May Cause Liver Injury | MT |
| 2022 | Shijiazhuang Yiling Pharmaceutical's Anti-Respiratory Disease Drug Enters Singaporean M.. | MT |
| 2022 | China stocks retreat on concerns of surging COVID cases | RE |
| 2022 | China stocks retreat on concerns of rising COVID cases | RE |
| 2022 | Investors bet on greed and fear as China loosens COVID grip | RE |
| 2022 | Tianjin Pharmaceutical Da Ren Tang Group Corporatio.. | CI |
| 2022 | Yiling to Boost Production of Traditional Herbal Medicine for Flu; Shares Rally 7% | MT |
| 2022 | Chinese rush to stock up antigen kits, medicines as COVID prevention curbs ease | RE |
| 2022 | Shandong Buchang Pharmaceuticals Unit Gets Registration Certificate for Anti-Lung Disea.. | MT |
| 2022 | Buchang Pharmaceutical's Lung Detoxifying Drug Gets Extension of Validity to 24 Months | MT |
| 2022 | China, HK stocks drop on COVID outbreaks, geopolitical risks | RE |
| 2022 | China, HK stocks drop on COVID outbreaks, geopolitical risks | RE |
| 2022 | Yiling Pharma Seeks Clinical Trial of Chinese Medicine Against Colds; Shares Rally 5% | MT |
| 2022 | Tianjin Pharmaceutical Profit Jumps 31% in Q3 on Higher Revenue | MT |
| 2022 | Dong-E-E-Jiao's January-September Profit Increases; Stock Rises 4% | MT |
| 2022 | Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30,.. | CI |
| 2022 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results f.. | CI |
| 2022 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Resignation of Z.. | CI |
| 2022 | Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months.. | CI |
| 2022 | Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Mont.. | CI |
| 2022 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months E.. | CI |
| 2022 | China Resources Angde Bio-Pharmaceutical Co., Ltd. announced that it expects to receive.. | CI |
| 2022 | Dong-E-E-Jiao Sees Nine-Month to September Profit Rise Up to 86% | MT |
| 2022 | Dong-E-E-Jiao Company Limited Provides Earnings Guidance for the Nine Months Ended 30 S.. | CI |
| 2022 | Buchang Pharmaceuticals Cleared to Launch Clinical Trial of Cancer Drug | MT |
| 2022 | Tianjin Pharmaceutical Da Ren Tang Group Corporatio.. | CI |
| 2022 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited agreed to acquire addition.. | CI |
| 2022 | Tianjin Pharmaceutical to Buy Controlling Stake in NewScen Coast Bio for $6 Million | MT |
| 2022 | NewScen Coast Bio-Pharmaceutical Co., Ltd announced that it expects to receive CNY 43.2.. | CI |
| 2022 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year End.. | CI |
| 2022 | Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year.. | CI |
| 2022 | Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year E.. | CI |
| 2022 | UBS Adjusts Dong-E E-Jiao's Price Target to 40.75 Yuan From 39.30 Yuan, Keeps at Neutra.. | MT |
| 2022 | Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 | CI |
| 2022 | Dong-E-E-Jiao Co.,Ltd. Announces Cash Dividend for the Year 2021, Payable on August 23,.. | CI |
| 2022 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results f.. | CI |
| 2022 | Changrui Biotechnology Co., Ltd. announced that it expects to receive CNY 64 million in.. | CI |
| 2022 | Tianjin Zhongxin Board OKs Use of $52 Million Placement Proceeds | MT |
| 2022 | Shandong Dongxin Investment Co., Ltd. announced that it expects to receive CNY 180 mill.. | CI |
| 2022 | Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Six Months Ended 30 June 2022 | CI |
| 2022 | Shijiazhuang Yiling Pharmaceutical Co., Ltd. Announces Final Dividend on Share A for 20.. | CI |
| 2022 | Dong-E-E-Jiao Co.,Ltd. Approves Cash Dividend for the Year 2021 | CI |
| 2022 | Tianjin Pharmaceutical Da Ren Tang Group Corporatio.. | CI |
| 2022 | Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021 | CI |
| 2022 | Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Announces Final Dividend for.. | CI |
| 2022 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Final Cash Dividend on A Shares for .. | CI |
| 2022 | Yiling Pharmaceutical's Q1 Profit Tumbles 28% as Sales Plummet | MT |
| 2022 | Tianjin Zhongxin Pharmaceutical Posts Lower Profit in January-March | MT |
| 2022 | Shijiazhuang Yiling Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year .. | CI |
| 2022 | Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Appoints Zhang Yu as Chief P.. | CI |
| 2022 | Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Reports Earnings Results for.. | CI |
| 2022 | Dong-E-E-Jiao's Profit, Revenue Rise in Q1; Shares Jump 5% | MT |
| 2022 | Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2.. | CI |
| 2022 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter.. | CI |
| 2022 | Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Qua.. | CI |
| 2022 | Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quart.. | CI |
| 2022 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2021 | CI |
| 2022 | Yiling Pharma's Shares Sink on Doubts Over COVID-19 Drug Efficacy | MT |
| 2022 | Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Three Months Ended 31 March 2.. | CI |
| 2022 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Cash Dividend for 2021 | CI |
| 2022 | Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Recommends to Declare Divide.. | CI |
| 2022 | Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Reports Earnings Results for.. | CI |
| 2022 | UBS Adjusts Dong-E-E-Jiao's Price Target to 39.3 Yuan From 37.5 Yuan, Keeps at Neutral | MT |
| 2022 | Dong-E-E-Jiao Co.,Ltd. Proposes Cash Dividend as of 31 December 2021 | CI |
| 2022 | Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 20.. | CI |
| 2022 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year End.. | CI |
| 2022 | Dong-E-E-Jiao Expects Higher Profit in 2021 | MT |
| 2022 | Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Year Ended December 31, 2021 | CI |
| 2021 | Sichuan Tianrunyuan Enterprise Management Co., Ltd., Pu Xiaoping, Wang Baocai, Li Weiju.. | CI |
| 2021 | Shunten International Limited Enters into Cooperation Framework Agreement with Shijiazh.. | CI |
| 2021 | Tianjin Zhongxin Pharmaceutical Elects New Chairman; Shares Slip 3% | MT |
| 2021 | Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Approves Election of Ms. Zha.. | CI |
| 2021 | Dong-E-E-Jiao Swings to Profit in January-September | MT |
| 2021 | Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30,.. | CI |
| 2021 | Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Reports Earnings Results for.. | CI |
| 2021 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months E.. | CI |
| 2021 | Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months.. | CI |
| 2021 | Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Appoints Mr. Xing Jianhua as.. | CI |
| 2021 | Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Appoints Ms. Zhang Mingrui a.. | CI |
| 2021 | Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Announces Resignation of Tan.. | CI |
| 2021 | Shandong Buchang Pharmaceuticals Co., Ltd. and Shandong Buchang Shenzhou Pharmaceutical.. | CI |
| 2021 | Dong E E Jiao : Forecasts Up to 164% Surge in Q3 Profit | MT |
| 2021 | Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced a financing transaction | CI |
| 2021 | Tianjin Zhong Xin Pharmaceutical : Zhongxin Board OKs U.. | MT |
| 2021 | Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Approves Appointment of Guo .. | CI |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
